Drug recall · March 12, 2014
Super-DMZ Rx 2.0 Capsules recall
Why: Marketed without an Approved NDA/ANDA; product contains the steroid ingredient 2, 17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one, making it an unapproved new drug
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Super-DMZ Rx 2.0 Capsules, 60 count bottles, Dietary Supplement, Lean muscle mass, hardness and strength, Manufactured for Blackstone Labs Boca Raton, FL 33433.
- Lots / codes
lot numbers: 1) M55Q (A) Exp 04/2016, 2) M55Q (2) Exp 05/16, 3)E07Q Exp unknown
- Quantity
- 11,200 bottles (60 capsules per bottle) (quantities for E07Q unknown)
- Company
- Mira Health Products Ltd., Farmingdale, NY
- Distribution
- Nationwide
- Initiated
- July 22, 2013 · Voluntary: Firm initiated
- Classified
- March 5, 2014
- Reported
- March 12, 2014
- Ended
- September 15, 2014
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.